Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Company
Tianjin Xinguan to build Lamivudine project2009-10-27
NHU's new equipments of Vitamin E & H into test run2009-10-26
NHU invests more money to build Vitamin E base2009-10-21
Tuoyang resumes the production of Sodium Erythorbate2009-10-21
CSPC Zhongrun to produce Erythromycin Thiocyanate2009-10-20
Huarong's Cobamamide DMF filed by US FDA2009-10-20
Haiyao plans to build cephalosporin intermediates project2009-10-19
Luwei signed Vitamin C supply contracts with 2 German firms2009-10-19
Alpharma to build 30 ton Vancomycin project2009-10-19
LingRui to found fentanyl transdermal patches project2009-10-13
Eli Lilly to double its workforce inside of China2009-10-13
United Laboratories raised 6-APA&Amoxicillin price2009-09-27
Tiantan Biotec to build new vaccine base2009-09-25
Two key producers got good profits from vitamin C in first half year2009-09-17
GSK research cooperation with Chinese firm2009-09-17
NCPC semisyntech got European GMP certificate2009-09-16
Abbott's coronary stent approved in China2009-09-16
SFDA approved Saint-gobain to produce glass infusion bottle2009-09-15
Saizhuo  plans to produce Biapenem and Pitavastatin Calcium2009-09-15
Merck acquires Suzhou Taizhu Technology2009-09-14
Xiantai Pharma got European GMP certificate2009-09-14
Shouguang Fukang export value increases2009-09-11
Lilly new diabetes drug launched Chinese market2009-09-11
Seretide Diskus's drug administrative protection expired2009-09-11
AstraZeneca begins construction work at Zhangjiang Hi-Tech Park2009-09-10
Calthium pantothenate：more fury market competition2009-09-10
Export value of Jincheng Chemical increases by 39%2009-09-09
One more firm enters vitamin premix market2009-09-09
Accord Pharma to extend workshops of sterile cephalosporin APIs2009-09-08
Yangtze River begins 2nd phase project of new drugs academe2009-09-08
United Laboratories increased 6-APA and Amoxicillin prices2009-09-07
Sinovac first batch H1N1 vaccine enter market2009-09-04
共2619个 页次:75/82页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463